Everon Biosciences Publishes a Study Suggesting a New Biomarker of Senescent Cells for Anti-Aging Research and Drug Development

BUFFALO, N.Y., Feb. 15, 2017 /PRNewswire/ -- Today, a research team from Everon Biosciences, Inc. and Roswell Park Cancer Institute has published a new study in Proceedings of the National Academy of Sciences of the United States of America (PNAS) describing a new biomarker of senescent cells and a specific monoclonal antibody that could potentially be used to develop [...]